Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

ClinicalTrials.gov ID: NCT00332241

Public ClinicalTrials.gov record NCT00332241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Double-Blind, Randomized, Placebo-Controlled, Flexible-Dosed, Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the effectiveness (how well the drug works) of aripiprazole, flexibly dosed with a placebo, in reducing serious behavioral problems in children and adolescents with a diagnosis of autistic disorder (AD).

Study identification

NCT ID
NCT00332241
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
98 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2006 (Actual)
Primary completion
Apr 1, 2008 (Actual)
Completion
Apr 1, 2008 (Actual)
Last update posted
May 13, 2026

2006 – 2008

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Marsella, Gregory Boca Raton Florida 33432 —
Child Neurology Associates, Pc Atlanta Georgia 30342 —
University Of Louisville Louisville Kentucky 40202 —
Neurobehavioral Medicine Group Bloomfield Hills Michigan 48302 —
Center For Psychiatry And Behavioral Medicine Las Vegas Nevada 89128 —
Suny - Stony Brook School Of Medicine Stony Brook New York 11794 —
Univ Of Nc Chapel Hill North Carolina 27599 —
Ut Medical Group Memphis Tennessee 38105 —
Red Oak Psychiatry Associates, Pa Houston Texas 77090 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00332241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00332241 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →